Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02508077
Title FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications

rectum cancer

colon cancer

Therapies

Fluorouracil + Irinotecan + Leucovorin

Panitumumab

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST